AngioDynamics

Quarterly Financials

Values in thousands 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Revenue
$72,004
$72,845
$67,491
$70,980
Gross Profit
38,857
39,906
36,724
35,941
EBITDA
-329
1,793
-1,926
-7,324
EBIT
-6,648
-5,070
-8,711
-14,141
Net Income
-4,407
-10,738
-12,798
-13,449
Net Change In Cash
72,004
72,845
67,491
70,980
Free Cash Flow
-14,957
1,676
-19,345
-580
Cash
44,760
54,089
55,005
76,056
Basic Shares
40,853
40,922
40,653
40,427

Annual Financials

Values in thousands 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Revenue
$303,914
$338,752
$316,219
$291,010
Gross Profit
154,698
174,246
165,732
156,788
EBITDA
-14,292
12,194
11,132
-8,899
EBIT
-42,004
-20,980
-18,365
-35,191
Net Income
-184,349
-52,442
-26,547
-31,548
Net Change In Cash
303,914
338,752
316,219
291,010
Cost of Revenue
15,752
-18,818
-6,274
Free Cash Flow
-33,926
-4,274
-11,491
10,382
Cash
76,056
44,620
28,825
48,161
Basic Shares
40,180
39,480
39,009
38,342

Earnings Calls

Quarter EPS
2025-02-28
-$0.08
2024-11-30
-$0.04
2024-08-31
-$0.11
2024-05-31
-$0.06